Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Stock
Equities
600332
CNE000001733
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.78 CNY | -0.61% |
|
-0.61% | -11.50% |
| Apr. 02 | Baiyunshan Pharma Gets Approval for Carbocisteine Oral Solution's Registration in Macau | MT |
| Apr. 02 | Baiyunshan Pharmaceutical Gets Nod for Marketing Transfer of Bone Health Drug | MT |
| Capitalization | 35.25B 5.17B 4.38B 4.03B 3.81B 7.07B 479B 7.19B 47.21B 18.51B 232B 19.4B 19B 818B | P/E ratio 2026 * |
11.8x | P/E ratio 2027 * | 11.2x |
|---|---|---|---|---|---|
| Enterprise value | 35.25B 5.17B 4.38B 4.03B 3.81B 7.07B 479B 7.19B 47.21B 18.51B 232B 19.4B 19B 818B | EV / Sales 2026 * |
0.43x | EV / Sales 2027 * | 0.42x |
| Free-Float |
49.74% | Yield 2026 * |
3.93% | Yield 2027 * | 4.12% |
| 1 day | -0.61% | ||
| 1 week | -0.61% | ||
| Current month | -0.35% | ||
| 1 month | -11.02% | ||
| 3 months | -9.13% | ||
| 6 months | -10.67% | ||
| Current year | -11.50% |
| 1 week | 22.7 |  | 23.05 |
| 1 month | 22.6 | | 25.54 |
| Current year | 22.6 | | 26.03 |
| 1 year | 22.6 | | 27.85 |
| 3 years | 22.6 | | 37.09 |
| 5 years | 22.6 | | 37.2 |
| 10 years | 21.5 | | 46.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hong Li
CEO | Chief Executive Officer | 59 | 2017-06-22 |
Hao Shan Zheng
PRN | Corporate Officer/Principal | 50 | - |
Jian Xiong Zheng
PRN | Corporate Officer/Principal | 56 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Hong Li
BRD | Director/Board Member | 59 | 2018-06-14 |
Ya Jin Chen
BRD | Director/Board Member | 63 | 2020-06-28 |
Min Huang
BRD | Director/Board Member | 62 | 2020-06-28 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.61% | -0.61% | -13.35% | -33.68% | 5.17B | |
| +2.55% | -1.32% | +10.37% | +148.97% | 830B | |
| -0.15% | -1.79% | +48.71% | +41.35% | 564B | |
| -0.29% | +0.21% | +20.46% | +29.28% | 369B | |
| +2.07% | +1.39% | +25.20% | +15.13% | 328B | |
| +1.72% | -0.74% | +49.33% | +27.86% | 318B | |
| +1.19% | -2.41% | +31.10% | +34.87% | 291B | |
| +3.13% | -1.94% | +52.65% | +3.53% | 294B | |
| +1.69% | +1.22% | +28.13% | +43.23% | 192B | |
| +1.24% | +8.21% | -38.18% | -55.23% | 182B | |
| Average | +1.25% | +0.15% | +21.44% | +25.53% | 337.27B | |
| Weighted average by Cap. | +1.47% | -0.62% | +26.82% | +53.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 81.82B 12B 10.17B 9.36B 8.85B 16.41B 1,111B 16.7B 110B 42.96B 538B 45.03B 44.09B 1,898B | 84.39B 12.38B 10.49B 9.65B 9.13B 16.92B 1,145B 17.22B 113B 44.31B 555B 46.44B 45.47B 1,957B |
| Net income | 3.14B 460M 390M 359M 340M 629M 42.6B 640M 4.2B 1.65B 20.65B 1.73B 1.69B 72.78B | 3.22B 472M 400M 368M 348M 646M 43.7B 657M 4.31B 1.69B 21.18B 1.77B 1.73B 74.66B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-04-17 | 22.78 ¥ | -0.61% | 7,931,513 |
| 26-04-16 | 22.92 ¥ | -0.35% | 8,446,242 |
| 26-04-15 | 23.00 ¥ | +0.61% | 9,627,877 |
| 26-04-14 | 22.86 ¥ | +0.53% | 6,019,696 |
| 26-04-13 | 22.74 ¥ | -0.79% | 7,548,734 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600332 Stock
Select your edition
All financial news and data tailored to specific country editions
